Loading organizations...
JMCR Partners is an investment firm that manages a diverse portfolio, including a specialized biotech venture fund. The firm deploys capital into early-stage companies, notably through its Viva Ventures Biotech Fund, which targets nascent drug discovery startups from initial concept to pre-clinical development. Their approach involves collaborating with a network of scientific general partners to identify and nurture foundational biotechnological advancements.
The firm originated as a family office in 2013, founded to oversee the private assets of its principal's family and close associates. This foundational insight into strategic wealth management and private equity evolved into a broader investment mandate, encompassing direct investments in various sectors and the formation of specialized funds.
JMCR Partners serves as a capital partner for promising startups, particularly within the life sciences sector, and manages diversified assets for its family office clientele. Their vision extends to fostering significant scientific breakthroughs by providing essential early-stage funding and strategic guidance, aiming to cultivate innovations with long-term societal impact and robust financial returns.
JMCR Partners has 1 tracked investment across 1 company. The latest tracked deal is $12.0M Series B in Bonti in April 2017.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 1, 2017 | Bonti | $12.0M Series B | Alexey Konov | ARCH Venture Partners, SignalFire, City Hill Ventures, Colt Ventures |